3.63
-0.82%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Fuan Pharmaceutical Group Co
Its shares trade on Shenzhen under the ticker 300194.SZ. It has been listed since 22 March 2011. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.74bn and net income of CN¥77.0m. At that date it held total assets of CN¥5.76bn and shareholders' equity of CN¥4.36bn.
Fuan Pharmaceutical (Group) Co., Ltd. is engaged in the research and development, manufacture, and sale of active pharmaceuticals and formulations. The company is headquartered in Chongqing, Chongqing. The company went IPO on 2011-03-22. is a China-based company principally engaged in the sales of Active Pharmaceutical Ingredients (APIs) and intermediates, preparations and pharmaceuticals. The firm's pharmaceutical products mainly include antibiotics, anti-tumor medicines, respiratory system medicines and specialty medicines. The firm distributes its products in domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 22 Mar 2011
- Employees
- 3,229
- Website
- fapharm.com ↗
Leadership
Pay as last reported
- Mr. Tianxiang WangChairman of the Board, since 2009CN¥455,000
- Mr. Tao HuangVice Chairman of the Board, since 2012CN¥212,500
- Mr. Xuesong yuChief Financial Officer, Finance Director, Deputy General Manager, Director, since 2009CN¥196,400
- Mr. Lu WangGeneral Manager, Director
- Ms. Jing FengDeputy General ManagerCN¥197,300
- Mr. Wei WangDeputy General Manager, since 2018
- Mr. Qin TangSecretary of the Board, Director, since 2009CN¥196,500
- Mr. Yong YangDirector
- Mr. Geng ChenIndependent Director
- Mr. Zhi DongIndependent Director
- Mr. Zhiqiang LiuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Fuan Pharmaceutical Group employs 3229 employees in Chongqing for pharmaceutical R&D and manufacturing.
- The company specializes in antibiotics, anti-tumor medicines, and respiratory system medicines for domestic and overseas markets.
- Fuan Pharmaceutical Group has been listed since 2011 with a strong focus on APIs and pharmaceutical formulations.
Weaknesses
- Fuan Pharmaceutical Group's business is limited to China's domestic market and overseas markets without specific regional expansion details.
- The company's product range includes antibiotics and anti-tumor medicines but lacks diversification in other pharmaceutical segments.
- Fuan Pharmaceutical Group has no mention of digital transformation initiatives in its business description.
Opportunities
- Fuan Pharmaceutical Group can expand its API sales to emerging markets in Asia and Africa.
- The growing demand for specialty medicines presents an opportunity for Fuan Pharmaceutical Group's product portfolio.
- Increasing global focus on respiratory system medicines offers potential market growth for Fuan Pharmaceutical Group.
Threats
- Fuan Pharmaceutical Group faces competition from other Chinese pharmaceutical companies in the API market.
- Regulatory changes in China's pharmaceutical industry could impact Fuan Pharmaceutical Group's manufacturing processes.
- Fuan Pharmaceutical Group's reliance on domestic market sales exposes it to economic fluctuations in China.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.